Glenn Sblendorio - Dec 9, 2021 Form 4 Insider Report for IVERIC bio, Inc. (ISEE)

Role
Chief Executive Officer, Director
Signature
/s/ Todd Anderman, as Attorney-in-Fact for Glenn P. Sblendorio
Stock symbol
ISEE
Transactions as of
Dec 9, 2021
Transactions value $
$0
Form type
4
Date filed
12/13/2021, 06:50 PM
Previous filing
Jun 14, 2021
Next filing
Dec 14, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISEE Common Stock Options Exercise +23.8K +8.4% 306K Dec 9, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISEE Restricted Stock Units Options Exercise $0 -23.8K -33.33% $0.00 47.5K Dec 9, 2021 Common Stock 23.8K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units.
F2 This total includes 6,249 shares acquired by the Reporting Person on September 16, 2019, 1,313 shares acquired by the Reporting Person on March 15, 2021, and 1,257 shares acquired by the Reporting Person on September 15, 2021, under the Registrant's 2016 Employee Stock Purchase Plan that were not previously reported.
F3 On December 9, 2019, the Reporting Person was granted an award of 95,000 restricted stock units, which vests with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan.